Glycosylation defining cancer malignancy: New wine in an old bottle

By S. Hakomori. Proceedings of the National Academy of Sciences of the United States of America, 2002

995 citations recorded by the source corpus.

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

Glycosylation in cellular mechanisms of health and disease. (2006, background): “For example, elevated levels of truncated O-glycans (known as T antigens ) can be prognostic for reduced survival of patients with certain types of cancer (Hakomori, 2002; Kobata and Amano, 2005).”
Protein-glycan interactions in the control of innate and adaptive immune responses (2008, background): “Changes in glycosylation have been shown to strongly associate with the development of cancer and metastasi”